Androgen therapy in constitutional delay of growth

Hormone Research

Volumn 59, Issue 6, 2003, Pages 270-275

  Lampit, Meir ^a   Hochberg, Ze'ev ^a,b  

^a MEYER CHILDREN S HOSPITAL   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Androgen; Constitutional delay of puberty; Oxandrolone; Puberty; Testosterone

Indexed keywords

ANDROGEN; GROWTH HORMONE; OXANDROLONE; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; TESTOSTERONE ENANTATE; TESTOSTERONE PROPIONATE;

ADOLESCENT; ANDROGEN THERAPY; ARTICLE; BODY HEIGHT; BONE AGE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; GROWTH RATE; GROWTH RETARDATION; HORMONE BLOOD LEVEL; HUMAN; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBERTY; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; TESTIS SIZE;

ADOLESCENT; ANDROGENS; BODY MASS INDEX; CHILD; DRUG ADMINISTRATION SCHEDULE; GROWTH; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; INJECTIONS; INSULIN-LIKE GROWTH FACTOR I; MALE; OXANDROLONE; PUBERTY; TABLETS; TESTOSTERONE; TESTOSTERONE PROPIONATE; TREATMENT OUTCOME;

EID: 0037679065     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070624     Document Type: Article

References (20)

1. Zachmann M: Therapeutic indications for delayed puberty and hypogonadism in adolescent boys. Horm Res 1991;36:141-146.
2. Karim A, Ranney RE, Zagarella BA, Maibach HI: Oxandrolone disposition and metabolism in man. Clin Pharmacol Ther 1973;14:862-869.
3. Masse R, Bi H, Ayotte C, Dugal R: Studies on anabolic steroids. II. Gas chromatographic/mass spectrometric characterization of oxandrolone urinary metabolites in man. Biomed Envir Mass Spect 1989;18:429-438.
4. Richman RA, Kirsch LR: Testosterone treatment in adolescent boys with constitutional delay in growth and development. N Engl J Med 1988;319:1563-1567.
5. Soliman AT, Khadir MM, Asfour M: Testosterone treatment in adolescent boys with constitutional delay of growth and development. Metabolism 1995;44:1013-1015.
6. Limbeck GA, Ruvalcaba RHA, Majoney CP, Kelly VC: Studies on anabolic steroids. IV. The effects of oxandrolone on height and skeletal maturation in uncomplicated growth retardation. Clin Pharmacol Ther 1971;12:798-805.
7. Bettmann HK, Goldman HS, Abramowicz M, Sobel EH: Oxandrolone treatment of short stature: Effect on predicted mature height. J Pediatr 1971;79:1018-1023.
8. Hochberg Z, Korman S: Oxandrolone therapy in boys of short stature. J Pediatr Endocrinol 1987;2:115-120.
9. Schroor EJ, van Weissenbruch MM, Knibbe P, Delemarre-van de Waal HA: The effect of prolonged administration of an anabolic steroid (oxandrolone) on growth in boys with constitutionally delayed growth and puberty. Eur J Pediatr 1995;154:953-957.
10. Tse WY, Buyukgebiz A, Hindmarsh PC, Stanhope R, Preece MA, Brook CGD: Long-term outcome of oxandrolone treatment in boys with constitutional delay of growth and puberty. J Pediatr 1990;117:588-591.
11. Wilson DM, McCauley E, Brown DR, Dudley R: Oxandrolone therapy in constitutionally delayed growth and puberty. Bio-Technology General Corporation Cooperative Study Group. Pediatrics 1995;96:1095-1100.
12. Fox M, Minot AS, Liddle GW: Oxandrolone: A potent anabolic steroid. J Clin Endocrinol Metab 1961;22:921-924.
13. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS: Estrogen resistance caused by a mutation in the estrogen-receptor gene in man. N Engl J Med 1994;331:1056-1061.
14. Grumbach MM, Auchus RJ: Estrogen: Consequences and implications of human mutations in synthesis and action. J Clin Endocrinol Metab 1999;84:4677-4694.
15. Crowne EC, Wallace WH, Moore C, Mitchell R, Robertson WH, Holly JM, Shalet SM: Effect of low dose oxandrolone and testosterone treatment on the pituitary-testicular and GH axes in boys with constitutional delay of growth and puberty. Clin Endocrinol (Oxf) 1997;46:209-216.
16. Malhotra A, Poon E, Tse WY, Pringle PJ, Hindmarsh PC, Brook CG: The effects of oxandrolone on the growth hormone and gonadal axes in boys with constitutional delay of growth and puberty. Clin Endocrinol (Oxf) 1993;38:393-398.
17. Ulloa-Aguirre A, Blizzard RM, Garcia-Rubi E, Rogol AD, Link K, Christie CM, Johnson ML, Veldhuis JD: Testosterone and oxandrolone, a nonaromatizable androgen, specifically amplify the mass and rate of growth hormone (GH) secreted per burst without altering GH secretory burst duration or frequency or the GH half-life. J Clin Endocrinol Metab 1990;71:846-854.
18. Zadik Z, Chalew SA, McCarter RJ Jr, Meistas M, Kowarski AA: The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals. J Clin Endocrinol Metab 1985;60:513-516
19. Forbes, GB, Porta CR, Herr BE, Griggs, RC: Sequence of changes in body composition induced by testosterone and reversal of changes after drug is stopped. JAMA 1992;267:397-399.
20. Preece MA: Prediction of adult height: Methods and problems. Acta Paediatr Scand Suppl 1988;347:4-11.